7.85
price down icon3.92%   -0.32
after-market Dopo l'orario di chiusura: 7.85
loading
Precedente Chiudi:
$8.17
Aprire:
$7.9
Volume 24 ore:
1.29M
Relative Volume:
1.49
Capitalizzazione di mercato:
$965.27M
Reddito:
$247.00M
Utile/perdita netta:
$-249.00M
Rapporto P/E:
-2.5405
EPS:
-3.09
Flusso di cassa netto:
$-267.00M
1 W Prestazione:
-13.93%
1M Prestazione:
-27.92%
6M Prestazione:
-48.66%
1 anno Prestazione:
-58.42%
Intervallo 1D:
Value
$7.56
$8.02
Intervallo di 1 settimana:
Value
$7.56
$9.14
Portata 52W:
Value
$7.56
$18.98

Arcus Biosciences Inc Stock (RCUS) Company Profile

Name
Nome
Arcus Biosciences Inc
Name
Telefono
(510) 694-6200
Name
Indirizzo
3928 POINT EDEN WAY, HAYWARD, CA
Name
Dipendente
0
Name
Cinguettio
@arcusbio
Name
Prossima data di guadagno
2024-12-06
Name
Ultimi documenti SEC
Name
RCUS's Discussions on Twitter

Confronta RCUS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
RCUS
Arcus Biosciences Inc
7.85 965.27M 247.00M -249.00M -267.00M -3.09
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

Arcus Biosciences Inc Stock (RCUS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-02-26 Aggiornamento H.C. Wainwright Neutral → Buy
2024-10-21 Iniziato H.C. Wainwright Neutral
2024-10-08 Iniziato Wells Fargo Overweight
2022-11-18 Iniziato BofA Securities Neutral
2022-10-11 Iniziato Morgan Stanley Overweight
2021-10-15 Ripresa BTIG Research Buy
2020-11-24 Iniziato Berenberg Buy
2020-11-23 Iniziato Evercore ISI Outperform
2020-04-03 Iniziato Cantor Fitzgerald Overweight
2020-03-04 Iniziato Barclays Overweight
2019-11-12 Iniziato SunTrust Buy
2019-09-27 Iniziato Mizuho Buy
2019-05-24 Ripresa Citigroup Buy
2018-10-09 Iniziato Wedbush Outperform
2018-04-09 Iniziato Citigroup Buy
2018-04-09 Iniziato Goldman Neutral
2018-04-09 Iniziato Leerink Partners Outperform
Mostra tutto

Arcus Biosciences Inc Borsa (RCUS) Ultime notizie

pulisher
Mar 29, 2025

Arcus Biosciences, Inc.'s (NYSE:RCUS) latest 8.6% decline adds to one-year losses, institutional investors may consider drastic measures - Yahoo Finance

Mar 29, 2025
pulisher
Mar 25, 2025

Arcus Biosciences Announces New Employment Inducement Grants - Bluefield Daily Telegraph

Mar 25, 2025
pulisher
Mar 25, 2025

Cancer Therapy Pioneer Arcus Biosciences Accelerates Growth with Key Team Expansion - Stock Titan

Mar 25, 2025
pulisher
Mar 17, 2025

RCUS stock touches 52-week low at $8.97 amid market challenges - Investing.com Australia

Mar 17, 2025
pulisher
Mar 17, 2025

RCUS stock touches 52-week low at $8.97 amid market challenges By Investing.com - Investing.com South Africa

Mar 17, 2025
pulisher
Mar 14, 2025

Arcus Biosciences, Inc. (RCUS): Among Top Insider Purchases Last Month - Insider Monkey

Mar 14, 2025
pulisher
Mar 14, 2025

RCUS FY2025 EPS Estimate Raised by Cantor Fitzgerald - Defense World

Mar 14, 2025
pulisher
Mar 13, 2025

Arcus Biosciences at Barclays Conference: Strategic Pipeline Insights By Investing.com - Investing.com Canada

Mar 13, 2025
pulisher
Mar 12, 2025

Top 10 Insider Purchases Last Month - Insider Monkey

Mar 12, 2025
pulisher
Mar 12, 2025

(RCUS) Investment Analysis - Stock Traders Daily

Mar 12, 2025
pulisher
Mar 12, 2025

Arcus Biosciences at Leerink’s Global Healthcare Conference: Strategic Advancements By Investing.com - Investing.com Canada

Mar 12, 2025
pulisher
Mar 10, 2025

RCUS stock touches 52-week low at $9.42 amid market challenges - Investing.com Australia

Mar 10, 2025
pulisher
Mar 09, 2025

Terry Rosen Increases Stake in Arcus Biosciences Inc (RCUS) with Recent Share Purchase - GuruFocus.com

Mar 09, 2025
pulisher
Mar 06, 2025

Little Excitement Around Arcus Biosciences, Inc.'s (NYSE:RCUS) Revenues As Shares Take 26% Pounding - Simply Wall St

Mar 06, 2025
pulisher
Mar 03, 2025

Arcus Biosciences (RCUS): Among Stocks With At Least $10 Million In Insider Spending Recently - Insider Monkey

Mar 03, 2025
pulisher
Mar 03, 2025

10 Stocks With At Least $10 Million In Insider Spending Recently - Insider Monkey

Mar 03, 2025
pulisher
Mar 02, 2025

Insider Buying: Arcus Biosciences Co-Founder Bought US$201k Of Shares - Yahoo Canada Finance

Mar 02, 2025
pulisher
Mar 01, 2025

Learn to Evaluate (RCUS) using the Charts - Stock Traders Daily

Mar 01, 2025
pulisher
Mar 01, 2025

Arcus Biosciences (NYSE:RCUS) Upgraded at HC Wainwright - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Wedbush Forecasts Arcus Biosciences’ Q1 Earnings (NYSE:RCUS) - Defense World

Mar 01, 2025
pulisher
Feb 28, 2025

Arcus Biosciences director Yasunori Kaneko buys $201,200 in shares By Investing.com - Investing.com South Africa

Feb 28, 2025
pulisher
Feb 28, 2025

Arcus Biosciences, Inc. (NYSE:RCUS) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Yahoo Finance UK

Feb 28, 2025
pulisher
Feb 28, 2025

What is Leerink Partnrs’ Forecast for RCUS Q1 Earnings? - Defense World

Feb 28, 2025
pulisher
Feb 27, 2025

Arcus Biosciences CEO Terry J. Rosen buys $201,465 in common stock - Investing.com Australia

Feb 27, 2025
pulisher
Feb 27, 2025

Arcus Biosciences CEO Terry J. Rosen buys $201,465 in common stock By Investing.com - Investing.com South Africa

Feb 27, 2025
pulisher
Feb 27, 2025

Arcus Biosciences director Yasunori Kaneko buys $201,200 in shares - Investing.com India

Feb 27, 2025
pulisher
Feb 27, 2025

Arcus Biosciences Executives Increase Their Holdings - TradingView

Feb 27, 2025
pulisher
Feb 27, 2025

RCUS stock touches 52-week low at $9.88 amid market challenges - Investing.com

Feb 27, 2025
pulisher
Feb 27, 2025

RCUS stock touches 52-week low at $9.88 amid market challenges By Investing.com - Investing.com South Africa

Feb 27, 2025
pulisher
Feb 26, 2025

Arcus Biosciences’ SWOT analysis: promising pipeline drives stock outlook By Investing.com - Investing.com South Africa

Feb 26, 2025
pulisher
Feb 26, 2025

HC Wainwright & Co. Upgrades Arcus Biosciences (RCUS) - Nasdaq

Feb 26, 2025
pulisher
Feb 26, 2025

Can Arcus Biosciences Reveal New Cancer Pipeline Updates at March Healthcare Conferences? - StockTitan

Feb 26, 2025
pulisher
Feb 26, 2025

Arcus Biosciences' SWOT analysis: promising pipeline drives stock outlook - Investing.com

Feb 26, 2025
pulisher
Feb 26, 2025

Arcus Biosciences’ SWOT analysis: promising pipeline drives stock outlook - Investing.com India

Feb 26, 2025
pulisher
Feb 26, 2025

Arcus Biosciences gains after H.C. Wainwright upgrades to "buy" - TradingView

Feb 26, 2025
pulisher
Feb 26, 2025

HC Wainwright Upgrades Arcus Biosciences to Buy From Neutral, Adjusts Price Target to $24 From $18 - Marketscreener.com

Feb 26, 2025
pulisher
Feb 26, 2025

Arcus Biosciences stock rating upgraded to Buy at H.C. Wainwright By Investing.com - Investing.com UK

Feb 26, 2025
pulisher
Feb 26, 2025

Arcus Biosciences Reports 2024 Financial Results and Pipeline Progress - TipRanks

Feb 26, 2025
pulisher
Feb 26, 2025

Arcus Biosciences reports Q4 EPS ($1.03), consensus ($1.20) - TipRanks

Feb 26, 2025
pulisher
Feb 26, 2025

Arcus Biosciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - MarketScreener

Feb 26, 2025
pulisher
Feb 25, 2025

Arcus Biosciences earnings beat by $0.20, revenue topped estimates - Investing.com Canada

Feb 25, 2025
pulisher
Feb 25, 2025

Arcus Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 25, 2025
pulisher
Feb 25, 2025

Arcus Biosciences, Inc. (RCUS) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Feb 25, 2025
pulisher
Feb 25, 2025

Earnings Flash (RCUS) Arcus Biosciences Posts Q4 Revenue $36M, vs. FactSet Est of $29.3M - Marketscreener.com

Feb 25, 2025
pulisher
Feb 25, 2025

Can Arcus Biosciences' Promising Cancer Drug Results Transform Kidney Cancer Treatment? - StockTitan

Feb 25, 2025
pulisher
Feb 25, 2025

Arcus Biosciences Inc (RCUS) Q4 2024: Everything You Need to Kno - GuruFocus.com

Feb 25, 2025
pulisher
Feb 25, 2025

Arcus Biosciences Inc (RCUS) Q4 2024: Everything You Need to Know Ahead of Earnings - Yahoo Finance

Feb 25, 2025
pulisher
Feb 24, 2025

Inside Arcus Biosciences' Latest Executive Compensation Package: Key Numbers Revealed - StockTitan

Feb 24, 2025
pulisher
Feb 23, 2025

The week in pharma: action, reaction and insight – week to February 21 - The Pharma Letter

Feb 23, 2025
pulisher
Feb 21, 2025

Arcus Biosciences Inc expected to post a loss of $1.25 a shareEarnings Preview - TradingView

Feb 21, 2025

Arcus Biosciences Inc Azioni (RCUS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
Capitalizzazione:     |  Volume (24 ore):